Financhill
Sell
11

CANF Quote, Financials, Valuation and Earnings

Last price:
$0.33
Seasonality move :
-12.9%
Day range:
$0.33 - $0.35
52-week range:
$0.28 - $2.33
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.91x
P/B ratio:
0.86x
Volume:
824.7K
Avg. volume:
13M
1-year change:
-78.68%
Market cap:
$5.4M
Revenue:
$677.2K
EPS (TTM):
--

Earnings Data

Next earnings date for CANF
--
Most recent earnings per share
-$1.52
Missed by $1.15
(Mar 28/2024)
Consensus Estimate
-$0.37
(Mar 28/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CANF Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2025 Q4 -- -- -- -- --
09/30/2025 Q3 -- -- -- -- --
08/11/2025 Q2 -- -- -- -- --
04/14/2025 Q1 -- -- -- -- --
03/28/2025 Q4 $150K -- -- -- --
12/27/2024 Q3 $150K -- -- -- --
08/29/2024 Q2 $150K -- -- -- --
06/24/2024 Q1 $150K -- -- -- --
03/28/2024 Q4 $200K $155K -$1.52 -$0.37 -$1.15
11/30/2023 Q3 -- -- -$0.43 -$0.43 -$0.00
08/25/2023 Q2 -- -- -$0.40 -$0.73 $0.32
05/26/2023 Q1 -- -- -$0.65 -$1.90 $1.25
03/24/2023 Q4 -- -- -- -$1.27 --
11/25/2022 Q3 -- -- -$1.30 -$1.05 -$0.25
08/25/2022 Q2 -- -- -$0.81 -$0.85 $0.04
05/26/2022 Q1 -- -- -$0.90 -$1.40 $0.50
03/24/2022 Q4 -- -- -$3.00 -$1.80 -$1.20
11/26/2021 Q3 -- -- -$3.00 -- --
08/26/2021 Q2 -- -- -$1.84 -- --
03/31/2021 Q1 -- -- -$1.16 -- --
03/25/2021 Q4 -- -- -- -- --
11/30/2020 Q3 -- -- -$1.67 -- --
08/27/2020 Q2 -- -- -$2.84 -- --
03/31/2020 Q1 -- -- -$9.00 -- --
12/31/2019 Q4 -- -- -$9.00 -- --
09/30/2019 Q3 -- -- -$7.39 -- --
06/30/2019 Q2 -- -- -$9.21 -- --
03/31/2019 Q1 -- -- -$12.00 -- --
12/31/2018 Q4 -- -- -$27.00 -- --
11/27/2018 Q3 -- -- -- -- --
06/30/2018 Q2 -- -- -$9.00 -- --
03/31/2018 Q1 -- -- -$15.00 -- --
12/31/2017 Q4 -- -- -$15.00 -- --
11/27/2017 Q3 -- -- -$12.00 -- --
09/01/2017 Q2 -- -- -$15.00 -- --
03/31/2017 Q1 -- -- -$15.00 -- --
12/31/2016 Q4 -- -- -$34.07 -- --
11/25/2016 Q3 -- -- -$24.81 -- --
06/30/2016 Q2 -- -- -$14.46 -- --
03/31/2016 Q1 -- -- -$16.66 -- --
12/31/2015 Q4 -- -- $8.76 -- --

Can-Fite BioPharma Ltd. Earnings Questions

  • How Much did Can-Fite BioPharma Ltd. Generate in Revenue Last Quarter?

    Can-Fite BioPharma Ltd. reported $155K worth of top line sales in its most recent quarter.

  • Did Can-Fite BioPharma Ltd. Beat Earnings Last Quarter?

    Can-Fite BioPharma Ltd. announced earnings per share of -$1.52 which represents a miss of analyst forecast a -$0.37 per share.

  • Is Can-Fite BioPharma Ltd. Profitable?

    Can-Fite BioPharma Ltd. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Can-Fite BioPharma Ltd. EPS Next Year?

    Can-Fite BioPharma Ltd.'s earnings are forecast to decrease from -$1.09 per share to -$1.85 per share next year representing a decrease of -7.87%.

  • When is Can-Fite BioPharma Ltd.'s Earnings Date?

    Currently, Can-Fite BioPharma Ltd. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 6, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Google Vs NVIDIA Stock: Which Is Best?
Google Vs NVIDIA Stock: Which Is Best?

Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…

How High Could NVIDIA Stock Go?
How High Could NVIDIA Stock Go?

NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…

Stock Ideas

Buy
51
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 61x

Buy
64
Is AAPL Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 38x

Buy
69
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Sell
47
PSTG alert for Dec 4

Pure Storage, Inc. [PSTG] is up 5.05% over the past day.

Sell
41
SMX alert for Dec 4

SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.

Sell
43
HY alert for Dec 4

Hyster-Yale, Inc. [HY] is up 1.92% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock